or Try an Advanced Search...

    Blood Cells Stocks List

    Symbol Grade Name % Change
    TEVA B Teva Pharmaceutical Industries 0.18
    AMGN C Amgen Inc. 1.61
    CERS D Cerus Corporation -2.19
    RCKT F Rocket Pharmaceuticals, Inc. -0.61
    FATE F Fate Therapeutics, Inc. 6.67
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Red Blood Cell Biotechnology Medicine Bone Drugs Hematology Pharmaceutical Products Platelet Active Pharmaceutical Ingredients Adult Stem Cell Allergy Anemia Asthma Biology Biopharmaceutical Birth Control Blood Blood Products Blood Transfusion Bone Disease

    Related ETFs - A few ETFs which own one or more of the above listed Blood Cells stocks.

    Symbol Grade Name Weight
    BBH B Market Vectors Biotech ETF 15.79
    ISRA B Market Vectors Israel ETF 10.55
    EIS B iShares MSCI Israel Capped Investable Market Index Fund 9.51
    IBBQ C Invesco Nasdaq Biotechnology ETF 9.33
    IBB C iShares Nasdaq Biotechnology Index Fund 9.25
    View all Blood Cells ETFs...
    Compare ETFs
    Compare BBH to IBB Compare IBBQ to IBB Compare ISRA to IBB

        Blood Cells Stocks Recent News

        Date Stock Title
        May 31 FATE Fate Therapeutics announces resignation of CFO Edward Dulac
        May 31 RCKT Rocket Pharmaceuticals (NASDAQ:RCKT) Is In A Good Position To Deliver On Growth Plans
        May 30 TEVA Teva wins FDA nod for new Austedo formulation
        May 30 RCKT EC grants orphan medicinal product status to Rocket’s RP-A601
        May 30 TEVA FDA approves Teva Pharmaceuticals’ AUSTEDO XR for TD and HD chorea
        May 29 TEVA Teva Announces AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets Now U.S. FDA Approved as a One Pill, Once-Daily Treatment Option for Clinically Therapeutic Doses (24–48 mg/day)
        May 29 FATE Fate Therapeutics to Present at 2024 Jefferies Global Healthcare Conference
        May 29 AMGN Amgen wins approval of first biosimilar of AstraZeneca's Soliris
        May 29 AMGN Amgen Secures FDA Nod For Rare-Disease Treatment Biosimilar Based On AstraZeneca's Drug
        May 29 AMGN Where Will Amgen Be in 3 Years?
        May 29 RCKT Rocket Pharmaceuticals Receives Orphan Medicinal Product Designation from the European Commission for RP-A601 for PKP2 Arrhythmogenic Cardiomyopathy
        May 29 AMGN FDA approves Amgen’s interchangeable biosimilar Bkemv
        May 28 AMGN Nvidia, advances in cancer research, climate change under Trump: Market Domination
        May 28 AMGN Tapping into the GLP-1 hype? Consider these pharma stocks.
        May 28 AMGN AMGEN TO PRESENT INNOVATIVE RESEARCH FROM ITS ROBUST ONCOLOGY PORTFOLIO AT ASCO 2024
        May 28 AMGN Beat the Market the Zacks Way: EverQuote, Micron, Amgen in Focus
        May 27 AMGN The Biggest Biotechnology Company in Europe
        May 26 AMGN Amgen's Catching Up to Novo Nordisk and Eli Lilly. Should You Buy It?
        May 26 AMGN The Biggest Publicly Traded Biotech Company
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Red Blood Cell Biotechnology Medicine Bone Drugs Hematology Pharmaceutical Products Platelet Active Pharmaceutical Ingredients Adult Stem Cell Allergy Anemia Asthma Biology Biopharmaceutical Birth Control Blood Blood Products Blood Transfusion Bone Disease
        Blood Cells

        A blood cell, also called a hematopoietic cell, hemocyte, or hematocyte, is a cell produced through hematopoiesis and found mainly in the blood. Major types of blood cells include red blood cells (erythrocytes), white blood cells (leukocytes), and platelets (thrombocytes). Together, these three kinds of blood cells add up to a total 45% of the blood tissue by volume, with the remaining 55% of the volume composed of plasma, the liquid component of blood.

        More about Blood Cells
        Browse All Tags